Menu
Back to Journals » Cancer Management and Research » Volume 13
Original Research
Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,816 | Dovepress* | 4,832+ | 270 | 5,102 | |
| PubMed Central* | 984 | 366 | 1,350 | ||
| Totals | 5,816 | 636 | 6,452 | ||
| *Since 1 November 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar